Thomson Medical Group has launched and priced $160 million of notes due 2029, according to an Oct 21 bourse filing.
The notes are issued under the group’s $1 billion multi-currency debt issuance programme, which was established on June 28, 2019.
The notes are set to carry an interest of 4.65% annum payable semi-annually in arrear, which will mature five years from the date of issue.
DBS Bank has been appointed as the sole global coordinator, while CIMB Bank Berhad, Singapore branch, DBS Bank and Maybank Securities, Oversea-Chinese Banking Corporation Limited and United Overseas Bank U11 Limited have been appointed as the joint lead managers and joint bookrunners of the notes.
The net proceeds from the notes are expected to go towards the refinancing of existing borrowings and general working capital of the group.
The notes are set to be issued on the Singapore Exchange S68 Securities Trading (SGX-ST) on Oct 29.
See also: ZICO Capital will no longer sponsor Sinocloud after Feb 25
Shares in Thomson Medical Group A50 closed 0.1 cents higher, or up 2.04%, at 5 cents on Oct 21.
